通过CERN技术改善临床肢体成像, 火星生物影像获得FDA批准. MARS Bioimaging gets FDA approval for portable CT scanner using CERN tech to improve limb imaging in clinics.

美国食品和药物管理局已批准MARS生物成像510 ((k) 的便携式光子计数CT扫描仪,用于诊所及护理中心的上肢成像. MARS Bioimaging has received U.S. FDA 510(k) clearance for its portable photon-counting CT scanner, designed for upper extremity imaging in clinics and point-of-care settings. 该设备使用CERN开发的Medipix3技术提供高分辨率三维图像,增强组织和材料差异化,有助于骨折评估,手术规划和植入物监测. The device uses CERN-developed Medipix3 technology to deliver high-resolution 3D images with enhanced tissue and material differentiation, aiding in fracture assessment, surgical planning, and implant monitoring. 通过该许可,医院以外的高级成像技术将得到更广泛的使用,促进健康公平和成本效益. The clearance supports broader access to advanced imaging outside hospitals, promoting health equity and cost efficiency.